Marshall Islands
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Marshall Islands (MH)
| 2011 | 7.0 thousand |
| 2024 | 6.0 thousand |
| 2050 | 9.0 thousand |
Marshall Islands is one of the 37 countries and territories in the Western Pacific Region. Marshall Islands have the second highest prevalence of diabetes (20-79 years) in the world.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPS 2018
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | - | 7.0 | 6.0 | 9.0 |
| Age-standardised prevalence of diabetes, % | - | 21.8 | 25.7 | 28.7 |
| Proportion of people with undiagnosed diabetes, % | - | - | 65.0 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 3.9 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 3.5 | 4.9 |
| Age-standardised prevalence of IFG, % | - | - | 13.8 | 14.2 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 3.0 | 1.9 | 2.7 |
| Age-standardised prevalence of IGT, % | - | 9.2 | 7.9 | 8.5 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 172.0 | 39.3 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 19.1 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 9.6 | 12.6 |
| Total diabetes-related health expenditure, ID million | - | - | 10.1 | 13.3 |
| Diabetes-related health expenditure per person, USD | - | 519.0 | 1,589.4 | 1,400.4 |
| Diabetes-related health expenditure per person, ID | - | - | 1,673.6 | 1,474.6 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | - | - |
| People with type 1 diabetes (0-19 y) | - | - | - | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | - | 32.7 | 25.1 | 34.6 |
| Population of children and adolescents (0-19 y) | - | - | - | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | - |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | - |
| Population of children and adolescents (0-19 y) | - |
